Skip to main content

2016 to 2022 Saw Drop in Rate of Opioid Prescriptions From Surgeons

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 8, 2023.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 7, 2023 -- From 2016 to 2022, there was a decrease in the rate and size of opioid prescriptions from U.S. surgeons, according to a research letter published online Dec. 7 in JAMA Network Open.

Jason Zhang, from the University of Michigan Medical School in Ann Arbor, and colleagues conducted a cross-sectional study to examine trends in opioid prescribing by surgeons from 2016 to 2022. The monthly surgical opioid dispensing rate (dispensed opioid prescriptions from surgeons per 100,000 people), monthly mean total morphine milligram equivalents (MMEs) per prescription, and monthly total MMEs per 100,000 people were examined.

During the study period, there were 140,586,250 opioid prescriptions for 67,922,137 patients. The researchers found that the monthly surgical opioid dispensing rate decreased 35.6 percent from 661.2 to 426.0 prescriptions per 100,000 people during January 2016 to December 2022. During January 2016 to January 2020, the rate decreased 0.89 percent per month, followed by a sharp decline then rebound during February to July 2020 and a 0.45 percent decline per month from August 2020 onward. During the study period, the monthly mean total MMEs per prescription decreased 46.4 percent, from 414.0 to 222.0, and the monthly total MMEs per 100,000 people decreased 65.5 percent, from 273,746 to 94,548. The decreases were less rapid after mid-2020.

"Despite large reductions in opioid prescribing, surgical opioid stewardship initiatives remain important," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted December 2023

Read this next

ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma

WEDNESDAY, June 5, 2024 -- Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among...

Odds of Death Lower With Surgery for Hip Fracture in Patients With Dementia

MONDAY, June 3, 2024 -- For community-dwelling patients with dementia and fracture of the femoral head and neck, the odds of death are lower for those treated surgically...

Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income

FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.